Sponsored Links
| Drugs for Rare Cancers Approved After Subpar Tests |
 |
 |
 |
| Medical News - General Medical News | |||
|
Drugs for rare cancers are allowed to hit the U.S. market based on low-quality clinical tests that raise concerns about both safety and efficacy, researchers said Monday. Source: Reuters Health Related MedlinePlus Pages: Medicines, Rare Diseases, Understanding Medical Research Read more: MedlinePlus Health News
|